Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Ltd

- close price
About

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]

Key Points

Business Overview:[1][2]
SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness

  • Market Cap Cr.
  • Current Price
  • High / Low /
  • Stock P/E
  • Book Value
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Figures in Rs. Crores

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Dec 2023 Dec 2024
Allegra Market Share (Allergy Category)
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Avil Market Share (Allergy Category)
% ・Standalone data
City Reach
Number of Cities ・Standalone data
Combiflam Annual Sales Volume
Million Tablets ・Standalone data
Combiflam Market Share (Pain Category)
% ・Standalone data
Combiflam Sales Velocity
Strips per minute ・Standalone data
DePURA Market Share (Vitamin D Category)
% ・Standalone data
Total Employees
Number ・Standalone data

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
60.40% 60.40% 60.40% 60.40% 71.27% 71.27% 71.27%
6.03% 5.22% 4.42% 4.52% 3.24% 2.94% 2.83%
22.60% 23.83% 25.35% 25.48% 16.89% 17.21% 17.33%
10.98% 10.56% 9.84% 9.59% 8.59% 8.58% 8.57%
No. of Shareholders 61,09158,58255,73451,85949,63248,80848,075

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents